Ipsen
Enguerran Mouly is a seasoned professional in the field of preclinical and translational research, currently serving as Team Manager and Principal Scientist in Preclinical Biomarkers and Translational Activities at Ipsen since May 2022. Previously, Enguerran held the position of Chargé de recherche expert at Institut Pasteur, where expertise was applied in precision medicine projects for hearing loss. Enguerran also served as a translational research consultant for Biotherapy Partners, focusing on AAV-mediated gene therapy. Earlier roles include heading the research department at Hybrigenics and managing research projects at INSERM and Université Denis Diderot. Enguerran Mouly completed a Doctorat in Biologie des cellules sanguines from Université Paris Cité and continues to enhance knowledge through ongoing education at Groupe MultiHealth.
Previous companies
This person is not in any teams
This person is not in any offices
Ipsen
22 followers
Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Disease.